Phoreus Biotech is driving scientific innovation through superior nanocarrier technology
Phoreus Biotech is a life sciences startup founded in 2018 and based in the Kansas City metro area. A discovery of Kansas State University, our Branched Amphipathic Peptide Capsules (BAPC®️) represent an entirely new class of nanocarrier technology. Even though our work is on the nanoscale, it doesn’t mean we aren’t focusing on the big picture. We believe our technology has the capacity to transform the global landscape of human, animal, plant and environmental health.
The problem with some nanocarriers
For too long now, research with nanoparticles has always required some level of tradeoff. A nanocarrier might transfect efficiently but be highly toxic to cells. Others might not cause an immune response but, due to their lack of biodegradability, build up in the environment over time. BAPC®️ not only overcome all the issues of existing nanocarriers but offer a level of customization that make them the superior choice for virtually any application.
Better delivery means better results
Successful results in the lab don’t always immediately translate well to commercially viable applications. Without an effective method of delivery, the full potential of new discoveries may never be realized. Our mission at Phoreus is to transform innovative new discoveries into tangible products that make a difference in people’s lives. This is why BAPC®️-assisted technology is already in use by government, commercial and academic scientists around the world.
Meet our leadership team below.
Our Leadership Team
Dr. Scott W. Nagely is an emergency medicine physician in Vail, Colorado and is affiliated with multiple hospitals in the area. He received his medical degree from University of Kansas School of Medicine and has been in practice for more than 20 years. Dr. Nagely specializes in Emergency Medicine, Internal Medicine, and Pediatrics.
Lynn Rundle is an agribusiness executive with broad experience in startups, strategy, sales and consulting leadership, operations, M&A, and business transformation. He has a reputation for leveraging a strong entrepreneurial mindset and creative drive in propelling agricultural businesses to the next level. He is a natural leader, with deep sales and operational expertise, regarded for starting and building successful businesses and leading highly complex initiatives.
Lynn serves as Chairman of the Board at Phoreus Biotechnology. Lynn previously served as Chief Executive Officer & Chairman of the Board at J&J Family of Farms and as Operating Partner, Agribusiness at Sequel Holdings. He has many years of experience in agribusiness and has worked as founder and CEO of 21st Century Grain Processing, a specialty grain-based ingredient manufacturer, from its inception in 1997 through its successful sale in 2010. He has created several other successful agribusinesses and has worked closely with the agribusiness community, acting as an entrepreneur, educator, and executive for various producer associations. He received his B.S and M.S. degrees in Agriculture Education from Kansas State University.
Brad Holliday is a dynamic and versatile leader with 25 years’ experience planning, directing, and executing initiatives to maximize the strategic use of human capital. Brad spearheaded organizational HR from startups to multibillion dollar Fortune 500 global companies including a North American Top 10 non-profit. He has expertise in healthcare, consulting, and technology.
He has managed corporate site HR leadership for a Fortune 75 ($26B) organization and has administered an HR budget of $24.5M. Brad has also optimized areas to advance business performance in key business metrics including profitability, innovation, and productivity. He received degrees from the Human Resources Executive Program from the University of Michigan, Business Administration from Baker College, and a Bachelor of Science, Human Resources Management from Friends University.